Online Intervention to Promote Change and Help-Seeking in Young Adults With Gambling and Trading … (NCT06681103) | Clinical Trial Compass
CompletedNot Applicable
Online Intervention to Promote Change and Help-Seeking in Young Adults With Gambling and Trading Problems
Spain1,112 participantsStarted 2024-12-20
Plain-language summary
The goal of this study is to investigate if personalized online normative feedback (PONF) can increase intention to change and help-seeking behaviors in young adults with gambling or trading problems in Spain. The main questions it aims to answer are:
1. Does PONF increase intention to change and help-seeking behaviors?
2. How does receiving PONF affect gambling and trading behaviors?
Researchers will compare three groups:
* Evaluation group: A control group with pre- and post-assessments.
* Delayed evaluation group: A control group with only a post-assessment, to control for the effect of the assessment.
* FNPO group: An intervention group receiving PONF after the initial evaluation and completing both pre- and post-assessments.
Participants will:
* Receive PONF or no feedback at the first evaluation.
* Complete initial and follow-up assessments after 12 weeks.
Who can participate
Age range
18 Years – 34 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Participants' eligibility will be assessed based on sociodemographic variables and measures of psychological distress, suicidal behavior, sleep quality and substance use. Eligible participants for the study on PONF's effect on intention to change and help-seeking behavior in young adults with gambling or trading problems must meet the following inclusion and exclusion criteria.
Inclusion Criteria:
* Engaged in trading or gambling activities (land-based or online) at least once per month in the past 60 days
* Aged 18-34 years
* Residing in Spain
* Provide informed consent to participate in initial online assessment, post-test, and follow-up
Exclusion Criteria:
* Currently undergoing psychological or psychiatric treatment
* Scoring above 3 on the Oviedo Infrequency Scale (Fonseca-Pedrero et al., 2009), indicating potential random/pseudorandom or dishonest responses.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.